ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,501 | 57.98199 | 1 | male | 1 | 33 | 33 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 41 | 461,451 | null | null | 39.75 | asian | 20.296875 | 55 | 0.743896 | 0.66394 | 4 | 0 | 0 | no | 0.1 | 0.5 | dnr after sadm | 31 | 75 | 12.898438 | 75 | 22 | 38 | 145 | 2.699707 | 3.599609 | 1.099854 | 132 | 7.619141 | 160 | 28 | 3,700 | null | null | <2 mo. follow-up | 2.932129 |
1,502 | 54.88599 | 0 | male | 0 | 10 | 443 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | under $11k | 0 | 39,274 | 19,644.2188 | 19,136.5469 | 20 | black | 19.597656 | 19 | 0.891968 | 0.81897 | 1 | 1 | 0 | no | 0.8 | 0.8 | no dnr | 10 | 65 | 14.199219 | 65 | 16 | 35.59375 | null | null | null | 1.599854 | 125 | null | null | 35 | 3,550 | 0 | 0 | no(M2 and SIP pres) | 0 |
1,503 | 31.84099 | 0 | female | 0 | 9 | 441 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 34,588 | 15,645.4297 | 19,370.5 | 12 | white | 18.199219 | 23 | 0.856934 | 0.681885 | 1 | 0 | 0 | metastatic | 1 | 0.9 | no dnr | 9 | 82 | 0.599976 | 115 | 12 | 39 | null | null | 0.599976 | 1.899902 | 136 | null | 261 | 46 | 2,915 | 0 | null | null | 0.494751 |
1,504 | 55.43298 | 0 | female | 0 | 9 | 441 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 35,245 | 16,080.6328 | 18,295.3281 | 18 | white | 20.296875 | 33 | 0.876953 | 0.832886 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 9 | 0 | 24.199219 | 0 | 0 | 36.19531 | 274.25 | 1.199951 | 10.099609 | 2.799805 | 142 | 7.349609 | null | 92 | 14 | null | 6 | SIP>=30 | 6 |
1,505 | 86.55396 | 1 | male | 0 | 10 | 37 | Coma | Coma | 1 | 7 | under $11k | 44 | 139,613 | 27,035.8438 | 28,399.7344 | 40 | white | 26.699219 | 39 | 0.130981 | 0.082993 | 6 | 0 | 0 | no | null | null | no dnr | 10 | 65 | 17.796875 | 104 | 32 | 36.79688 | 148.3125 | null | null | 1 | 144 | 7.489258 | 118 | 21 | 2,075 | null | 0 | <2 mo. follow-up | 0 |
1,506 | 36.89297 | 1 | female | 0 | 54 | 64 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | under $11k | 44 | 556,242 | 116,165.5 | 84,961.5 | 21.75 | black | 25.199219 | 30 | 0.685913 | 0.592896 | 44 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 54 | 83 | 2.5 | 80 | 22 | 35.79688 | null | 4.199219 | 0.799927 | 0.799927 | 133 | null | null | 3 | 3,000 | null | 5 | null | 5 |
1,507 | 68.51196 | 1 | male | 0 | 58 | 240 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | under $11k | 26 | 265,912 | null | null | 27.25 | black | 38.195313 | 61 | 0.28595 | 0.175995 | 4 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 58 | 55 | 6.5 | 115 | 16 | 35.89844 | null | null | null | 1.799805 | 137 | null | null | 26 | 1,375 | null | 5 | SIP>=30 | 5 |
1,508 | 34.23999 | 0 | female | 0 | 18 | 436 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 120,821 | 55,423.3438 | 49,301.0312 | 25.333328 | white | 18.199219 | 18 | 0.93689 | 0.892944 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 18 | 58 | 10.599609 | 115 | 31 | 38.19531 | 162.5 | 3.899902 | 31 | 4.199219 | 135 | 7.489258 | 174 | 83 | 0 | 0 | null | no(M2 and SIP pres) | 0.494751 |
1,509 | 75.28296 | 1 | female | 0 | 50 | 235 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 542,002 | 152,701.875 | 146,630.375 | 39 | white | 33.898438 | 56 | 0.45697 | 0.337952 | 11 | 1 | 0 | no | null | null | no dnr | 50 | 55 | 8.699219 | 70 | 20 | 36.09375 | null | 3.399902 | 1 | 1.599854 | 135 | null | null | 38 | 2,425 | null | null | null | 2.881836 |
1,510 | 77.54999 | 0 | female | 0 | 51 | 434 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 9 | 382,453 | 145,990.75 | 140,280.125 | 43.5 | white | 29 | 62 | 0.53894 | 0.424988 | 10 | 0 | 0 | no | 0.2 | 0.2 | no dnr | 51 | 67 | 14.798828 | 74 | 22 | 36.19531 | null | 3.299805 | 3.899902 | 3.099609 | 136 | null | 85 | 80 | 590 | null | null | null | 2.792481 |
1,511 | 30.97899 | 0 | male | 0 | 39 | 435 | Coma | Coma | 0 | 12 | null | 61 | 229,100 | 103,634.5 | 90,354.6875 | 26.75 | hispanic | 22 | 35 | 0.746948 | 0.699951 | 1 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 39 | 75 | 14.298828 | 120 | 44 | 39 | 157.125 | 2.199707 | 0.799927 | 1.699951 | 139 | 7.509766 | 438 | 32 | 2,635 | null | 0 | no(M2 and SIP pres) | 0 |
1,512 | 63.63898 | 1 | female | 1 | 55 | 55 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | $11-$25k | 26 | 902,281 | 191,182.375 | 179,734.125 | 37 | hispanic | 34.296875 | 65 | 0.360962 | 0.242981 | 39 | 0 | 0 | no | 0.1 | 0.1 | dnr after sadm | 46 | 57 | 23.898438 | 105 | 9 | 36.59375 | 256 | null | 38.398438 | 3.299805 | 138 | 7.439453 | 109 | 66 | 1,965 | null | null | <2 mo. follow-up | 3.065918 |
1,513 | 46.935 | 0 | female | 0 | 28 | 432 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 61 | 160,986 | null | null | 18.25 | white | 23.5 | 28 | 0.619995 | 0.515991 | 2 | 0 | 0 | yes | 0.95 | 0.9 | no dnr | 28 | 75 | 10.599609 | 60 | 14 | 36 | null | null | null | 0.699951 | 133 | null | 202 | 22 | null | null | null | null | 4.486328 |
1,514 | 45.27597 | 1 | female | 0 | 14 | 46 | CHF | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 76,227 | 28,078.3281 | 27,865.7656 | 17.666656 | black | 33.5 | 73 | 0.75 | 0.605957 | 1 | 1 | 0 | no | 0.5 | 0.4 | no dnr | 14 | 75 | 11.298828 | 75 | 25 | 38.19531 | 215 | 2.299805 | 2.099609 | 1.699951 | 134 | 7.509766 | null | 30 | 1,651 | null | null | <2 mo. follow-up | 3.168945 |
1,515 | 39.86899 | 1 | male | 1 | 30 | 30 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 26 | 497,787 | 114,284.062 | 106,068.875 | 34 | white | 45.398438 | 78 | 0.022999 | 0.004999 | 37 | 0 | 0 | yes | 0.05 | 0 | dnr after sadm | 29 | 62 | 6.5 | 115 | 24 | 36.5 | null | null | null | 0.799927 | 136 | null | 188 | 19 | 3,600 | null | null | <2 mo. follow-up | 2.560059 |
1,516 | 65.73596 | 0 | male | 0 | 23 | 430 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 37 | 195,264 | 97,759.1875 | 83,391 | 39.666657 | white | 32.5 | 63 | 0.477966 | 0.359985 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 23 | 71 | 4.199219 | 120 | 24 | 38.39844 | null | 3.699707 | 2.399902 | 0.599976 | 139 | null | 138 | 6 | 3,350 | null | null | no(M2 and SIP pres) | 3.458008 |
1,517 | 49.34198 | 1 | female | 1 | 17 | 17 | Coma | Coma | 2 | 22 | $25-$50k | 44 | 201,340 | 37,985.2188 | 36,139.25 | 36.333313 | hispanic | 17 | 23 | 0.688965 | 0.633911 | 34 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 7 | 115 | 31.796875 | 95 | 16 | 36.79688 | 524 | null | null | 1.199951 | 155 | 6.959961 | 651 | 14 | 2,400 | null | 5 | <2 mo. follow-up | 5 |
1,518 | 59.35397 | 1 | female | 0 | 9 | 218 | Colon Cancer | Cancer | 1 | 18 | null | 0 | 30,984 | 14,547.3594 | 16,878.5781 | 14 | white | 14.298828 | 16 | 0.85791 | 0.684937 | 1 | 0 | 0 | metastatic | 1 | 0.9 | no dnr | 9 | 108 | 11 | 135 | 10 | 37 | 227.5 | null | null | 2.199707 | 153 | 7.509766 | 125 | 59 | 1,852 | 0 | 0 | no(M2 and SIP pres) | 0 |
1,519 | 73.52795 | 0 | female | 0 | 5 | 424 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 5,988 | 3,484.082 | 3,056.75 | 6 | white | 15.898438 | 6 | 0.868896 | 0.783936 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 5 | 97 | 16.296875 | 140 | 28 | 36.59375 | 226.65625 | null | null | 0.599976 | 137 | 7.529297 | null | 3 | 2,416 | null | null | null | 2.569336 |
1,520 | 71.18695 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 20 | >$50k | 41 | 201,762 | 29,839.5781 | 28,500.9062 | 56.5 | asian | 50.695313 | 75 | 0.007 | 0.001 | 9 | 1 | 0 | no | 0.4 | 0.1 | dnr after sadm | 6 | 52 | 4.899414 | 60 | 24 | 33.39844 | null | null | null | 4.199219 | 144 | null | 117 | 43 | 759 | null | 1 | <2 mo. follow-up | 1 |
1,521 | 60.22198 | 1 | male | 0 | 16 | 19 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 53,341 | 26,078.8125 | 28,201.2969 | 26 | black | 20.699219 | 33 | 0.86792 | 0.780884 | 1 | 1 | 0 | no | 0.8 | 0.5 | no dnr | 16 | 65 | 11.5 | 70 | 24 | 35.89844 | null | null | null | 0.899902 | 134 | null | 104 | 18 | 2,675 | null | null | <2 mo. follow-up | 3.364258 |
1,522 | 75.29895 | 1 | male | 0 | 54 | 239 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $11-$25k | 9 | 361,878 | 102,817.562 | 90,455.375 | 32.5 | white | 33.898438 | 72 | 0.297974 | 0.186981 | 24 | 0 | 0 | yes | 0.5 | 0.45 | no dnr | 54 | 60 | 15.298828 | 110 | 10 | 36.5 | 112 | null | null | 5.199219 | 136 | 7.519531 | 165 | 130 | 1,136 | null | 0 | adl>=4 (>=5 if sur) | 0 |
1,523 | 66.53497 | 1 | male | 0 | 7 | 172 | CHF | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 22,157 | 10,879.25 | 9,364.84375 | 17.5 | asian | 22.597656 | 33 | 0.826904 | 0.717896 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 7 | 62 | 31.199219 | 155 | 22 | 38.29688 | 93.84375 | 1.599854 | 0.299988 | 0.699951 | 135 | 7.389648 | 175 | 21 | 4,280 | null | null | null | 2.81543 |
1,524 | 20.29599 | 1 | female | 1 | 40 | 40 | MOSF w/Malig | ARF/MOSF | 2 | 12 | null | 0 | 355,578 | null | null | 35.25 | hispanic | 47.398438 | 67 | 0.07399 | 0.026997 | 2 | 0 | 0 | metastatic | 0.9 | 0.9 | no dnr | 40 | 122 | 21.199219 | 155 | 10 | 38 | null | 3.799805 | 0.5 | 1.199951 | 143 | null | 122 | 8 | 2,397 | null | 1 | <2 mo. follow-up | 1 |
1,525 | 68.82098 | 0 | female | 0 | 7 | 419 | COPD | COPD/CHF/Cirrhosis | 5 | 12 | under $11k | 0 | 21,750 | 11,069.8047 | 9,266.08594 | 13.5 | white | 26.898438 | 52 | 0.746948 | 0.600952 | 1 | 1 | 0 | no | 0.8 | 0.5 | no dnr | 7 | 113 | 38.59375 | 105 | 9 | 38 | 342.5 | 4.099609 | 15.398438 | 4.399414 | 133 | 7.449219 | 123 | 170 | 0 | 4 | 6 | null | 6 |
1,526 | 60.29797 | 0 | female | 0 | 11 | 415 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 51,183 | 23,294.4844 | 26,903.875 | 22 | white | 26.097656 | 56 | 0.792969 | 0.724976 | 1 | 0 | 0 | no | null | null | no dnr | 11 | 82 | 13.798828 | 120 | 32 | 39.59375 | 590 | 3.799805 | null | 0.799927 | 136 | 7.469727 | null | 8 | 2,735 | null | null | null | 2.783691 |
1,527 | 87.35394 | 1 | female | 0 | 4 | 210 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 9 | 11,602 | 5,440.957 | 5,021.9375 | 9 | white | 17.5 | 27 | 0.797974 | 0.67395 | 1 | 0 | 1 | no | 0.95 | 0.85 | dnr after sadm | 1 | 47 | 20.5 | 154 | 38 | 35.59375 | 138.75 | null | 0.799927 | 7.699219 | 152 | 7.429688 | 224 | 125 | 0 | null | null | no(M2 and SIP pres) | 5.25 |
1,528 | 58.32999 | 1 | female | 0 | 13 | 147 | MOSF w/Malig | ARF/MOSF | 1 | 8 | under $11k | 9 | 57,209 | 19,964.7031 | 19,905.25 | 14.5 | white | 27.699219 | 57 | 0.425964 | 0.306946 | 6 | 0 | 0 | metastatic | 0.7 | 0.5 | dnr after sadm | 1 | 113 | 14.298828 | 150 | 30 | 36.39844 | 161.21875 | 3.799805 | 0.599976 | 6.199219 | 130 | 7.40918 | 408 | 62 | 0 | null | 6 | adl>=4 (>=5 if sur) | 6 |
1,529 | 79.12897 | 1 | female | 0 | 9 | 59 | COPD | COPD/CHF/Cirrhosis | 3 | 13 | under $11k | 0 | 25,770 | 11,566.8984 | 8,506.60938 | 12.5 | white | 17.296875 | 31 | 0.826904 | 0.717896 | 1 | 0 | 0 | no | 0.9 | 0.5 | no dnr | 9 | 52 | 0.049995 | 115 | 14 | 37.5 | 226.0625 | null | 18.5 | 2.099609 | 134 | 7.399414 | 111 | 58 | 3,149 | 2 | null | <2 mo. follow-up | 1.838867 |
1,530 | 41.09799 | 0 | male | 0 | 8 | 411 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | $25-$50k | 0 | 43,026 | 18,923.1094 | 19,165.8281 | 20.5 | hispanic | 29.597656 | 47 | 0.794922 | 0.727905 | 2 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 8 | 57 | 13.398438 | 140 | 10 | 36.39844 | 230 | 3.099609 | 2 | 2.899902 | 151 | 7.439453 | 153 | 108 | 2,420 | 0 | 0 | null | 0 |
1,531 | 72.13995 | 1 | male | 1 | 7 | 7 | Lung Cancer | Cancer | 3 | 12 | $11-$25k | 0 | 30,670 | 13,482.5156 | 12,862 | 26.5 | black | 22.699219 | 39 | 0.556885 | 0.234985 | 1 | 1 | 0 | metastatic | 0.3 | 0.1 | dnr after sadm | 2 | 130 | 8.199219 | 110 | 6 | 37.5 | 370 | 2.599609 | 0.899902 | 0.899902 | 144 | 7.579102 | 333 | 8 | 3,020 | null | 1 | <2 mo. follow-up | 1 |
1,532 | 40.74698 | 0 | male | 0 | 64 | 408 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 16 | null | 26 | 310,749 | 128,527.625 | 111,230.562 | 31 | white | 48.59375 | 83 | 0.211975 | 0.116989 | 2 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 64 | 69 | 7.5 | 74 | 16 | 36.39844 | null | null | 0.599976 | 1.099854 | 135 | null | 78 | 12 | 1,525 | null | 0 | adl>=4 (>=5 if sur) | 0 |
1,533 | 66.67798 | 1 | male | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 192,030 | 43,920.3438 | 38,370.5312 | 24.666656 | hispanic | 16.097656 | 16 | 0.804932 | 0.73999 | 41 | 0 | 0 | yes | 0.5 | 0.1 | dnr after sadm | 18 | 89 | 8 | 86 | 22 | 36.79688 | 392 | null | null | 0.899902 | 132 | 7.399414 | null | 13 | null | null | 1 | <2 mo. follow-up | 1 |
1,534 | 32.008 | 1 | male | 1 | 43 | 43 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 44 | 348,165 | null | null | 25.25 | hispanic | 24.699219 | 36 | 0.724976 | 0.640991 | 25 | 0 | 0 | no | 0.5 | 0.3 | dnr after sadm | 5 | 52 | 18.5 | 135 | 16 | 38.09375 | 98.5625 | 2.899902 | 33.5 | 2.699707 | 144 | 7.489258 | 249 | 76 | 3,850 | null | null | <2 mo. follow-up | 3.895996 |
1,535 | 62.32397 | 1 | female | 1 | 66 | 66 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 41 | 916,502 | null | null | 41 | white | 35.5 | 64 | 0.261963 | 0.155975 | 27 | 0 | 0 | no | 0.9 | 0.8 | dnr after sadm | 64 | 65 | 11.699219 | 80 | 24 | 35.89844 | null | null | 1.299805 | 2 | 137 | null | 147 | 79 | 4,330 | null | 3 | adl>=4 (>=5 if sur) | 3 |
1,536 | 54.96799 | 0 | male | 0 | 43 | 403 | MOSF w/Malig | ARF/MOSF | 1 | 14 | null | 26 | 347,848 | 94,807.5 | 85,532.375 | 30.5 | white | 24.398438 | 46 | 0.401978 | 0.282959 | 18 | 0 | 0 | metastatic | 0.55 | 0.5 | no dnr | 43 | 70 | 36.296875 | 170 | 47 | 37.59375 | 124.48438 | null | null | 1.799805 | 149 | 7.469727 | 279 | 43 | 1,494 | null | 1 | SIP>=30 | 1 |
1,537 | 40.82098 | 0 | male | 0 | 12 | 403 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 26 | 58,518 | 25,931.4062 | 29,012.9062 | 36.5 | white | 23.597656 | 48 | 0.828979 | 0.770996 | 1 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 12 | 62 | 5.799805 | 105 | 16 | 36 | null | null | null | 1.799805 | 133 | null | 202 | 71 | 2,120 | null | 0 | no(M2 and SIP pres) | 0 |
1,538 | 69.48096 | 0 | female | 0 | 11 | 399 | Colon Cancer | Cancer | 1 | 11 | under $11k | 0 | 30,978 | 13,760.3516 | 15,334.9453 | 15 | hispanic | 4.799805 | 15 | 0.92395 | 0.821899 | 1 | 0 | 0 | metastatic | 1 | 0.9 | no dnr | 11 | 32 | 0.049995 | 155 | 22 | 39 | null | null | 1.199951 | 1.099854 | 133 | null | null | 10 | 7,750 | null | 0 | null | 0 |
1,539 | 58.793 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 234,692 | 24,678.2344 | 22,899.5312 | 48 | white | 67.796875 | 111 | 0 | 0 | 42 | 0 | 0 | yes | 0.5 | 0.5 | dnr after sadm | 4 | 111 | 10.199219 | 104 | 34 | 36 | 122.5 | null | null | 0.899902 | 138 | 7.30957 | null | 22 | 49 | null | null | <2 mo. follow-up | 1.963379 |
1,540 | 52.22699 | 0 | female | 0 | 22 | 398 | Coma | Coma | 1 | 7 | null | 44 | 192,402 | 48,440.875 | 48,410.0625 | 24.666656 | white | 22.199219 | 27 | 0.576904 | 0.510986 | 8 | 0 | 0 | no | null | null | no dnr | 22 | 72 | 6.599609 | 115 | 12 | 38.29688 | 547.5 | null | null | 4.099609 | 143 | 7.119141 | 395 | 50 | 2,535 | null | null | no(M2 and SIP pres) | 2.266602 |
1,541 | 94.54895 | 1 | female | 1 | 13 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 55 | 88,695 | 36,447.625 | 38,428.4062 | 32 | black | 33 | 37 | 0.177979 | 0.090988 | 1 | 0 | 0 | no | 0.15 | 0.05 | dnr after sadm | 7 | 107 | 13.798828 | 64 | 24 | 36.79688 | 195.21875 | 3.599609 | null | 0.899902 | 140 | 7.349609 | 175 | 13 | 1,500 | null | 6 | <2 mo. follow-up | 6 |
1,542 | 49.70599 | 0 | male | 0 | 73 | 396 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 11 | $11-$25k | 26 | 910,119 | 177,845.75 | 149,915.625 | 45.75 | hispanic | 34.5 | 59 | 0.454956 | 0.335999 | 32 | 0 | 0 | no | 0.3 | 0.3 | no dnr | 73 | 132 | 15.798828 | 110 | 46 | 36.79688 | 190.46875 | null | null | 1.899902 | 142 | 7.509766 | 114 | 38 | 2,200 | null | 0 | no(M2 and SIP pres) | 0 |
1,543 | 77.06494 | 1 | male | 0 | 8 | 66 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 26 | 26,899 | 11,858.2734 | 11,839.2891 | 18.5 | white | 16.5 | 25 | 0.807983 | 0.743896 | 1 | 0 | 1 | no | null | null | dnr after sadm | 1 | 137 | 5.899414 | 65 | 24 | 36 | 247.59375 | null | null | 0.799927 | 135 | 7.469727 | 92 | 19 | 2,200 | null | null | null | 5.412109 |
1,544 | 65.95996 | 1 | male | 1 | 8 | 8 | MOSF w/Malig | ARF/MOSF | 3 | 12 | under $11k | 100 | 68,139 | 26,086.8594 | 30,802.7656 | 35 | white | 33.09375 | 60 | 0.042 | 0.011999 | 1 | 0 | 0 | yes | 0.2 | 0.5 | no dnr | 8 | 62 | 17.5 | 55 | 0 | 36.19531 | 206.65625 | null | 1.299805 | 2.399902 | 142 | 7.40918 | 139 | 39 | 5,210 | null | 6 | <2 mo. follow-up | 6 |
1,545 | 42.82797 | 0 | male | 0 | 14 | 394 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 20 | >$50k | 26 | 85,800 | 32,954.5312 | 36,539.3125 | 33 | white | 31.398438 | 55 | 0.691895 | 0.599976 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 14 | 78 | 7.799805 | 125 | 28 | 36.09375 | null | null | 0.399963 | 1.399902 | 135 | null | 199 | 46 | 1,687 | null | 0 | no(M2 and SIP pres) | 0 |
1,546 | 86.71594 | 0 | female | 0 | 11 | 394 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | under $11k | 0 | 25,502 | 11,281.9609 | 9,619.875 | 14 | white | 17.398438 | 20 | 0.826904 | 0.767944 | 1 | 0 | 0 | no | 0.95 | 0.85 | no dnr | 11 | 35 | 13 | 120 | 26 | 38.5 | 128 | 3.899902 | 2.099609 | 7.899414 | 138 | 7.429688 | 119 | 88 | 0 | 0 | 0 | no(M2 and SIP pres) | 0 |
1,547 | 68.07397 | 1 | male | 0 | 9 | 43 | COPD | COPD/CHF/Cirrhosis | 1 | 8 | $11-$25k | 0 | 66,904 | 19,334.0625 | 17,372.3594 | 27 | white | 29.296875 | 24 | 0.585938 | 0.393982 | 5 | 0 | 0 | yes | 0.5 | 0.2 | no dnr | 9 | 73 | 6.299805 | 75 | 22 | 36.5 | 260 | null | 1.099854 | 1 | 134 | 7.5 | null | 6 | 2,622 | 5 | 6 | <2 mo. follow-up | 6 |
1,548 | 50.56299 | 0 | male | 0 | 31 | 391 | Coma | Coma | 1 | 16 | >$50k | 44 | 232,891 | 96,200.25 | 90,288.8125 | 39 | white | 19 | 15 | 0.690918 | 0.635986 | 4 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 31 | 102 | 20.898438 | 125 | 54 | 38.59375 | 435 | null | null | 1.099854 | 145 | 7.25 | 100 | 13 | 5,400 | null | null | null | 2.170898 |
1,549 | 60.54498 | 1 | male | 1 | 31 | 31 | MOSF w/Malig | ARF/MOSF | 1 | 16 | >$50k | 26 | 239,928 | 76,509.625 | 71,946 | 26.5 | white | 25.5 | 41 | 0.444946 | 0.325989 | 19 | 0 | 0 | yes | 0.2 | 0.15 | dnr after sadm | 12 | 108 | 22 | 125 | 35 | 36.39844 | null | null | 11.398438 | 2.099609 | 146 | 7.519531 | 220 | 73 | 3,100 | null | 4 | <2 mo. follow-up | 4 |
1,550 | 45.81497 | 0 | female | 0 | 168 | 391 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | >$50k | 44 | 1,161,504 | null | null | 40.25 | hispanic | 40.195313 | 86 | 0.356995 | 0.238983 | 1 | 0 | 0 | no | 0.3 | 0.15 | no dnr | 168 | 67 | 5.699219 | 145 | 36 | 39.59375 | 291.8125 | null | null | 1.199951 | 135 | 7.5 | 108 | 20 | 1,561 | null | 0 | no(M2 and SIP pres) | 0 |
1,551 | 81.57397 | 1 | male | 0 | 9 | 64 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | $25-$50k | 0 | 19,878 | 11,246.7969 | 9,558.08594 | 12.5 | white | 16.199219 | 17 | 0.817993 | 0.704956 | 1 | 0 | 0 | yes | 0.9 | 0.75 | no dnr | 9 | 62 | 6.5 | 115 | 27 | 38.5 | 192 | null | null | 1.099854 | 131 | 7.369141 | 502 | 20 | 4,590 | 2 | null | adl>=4 (>=5 if sur) | 1.838867 |
1,552 | 83.35895 | 1 | female | 1 | 5 | 5 | Coma | Coma | 2 | null | $25-$50k | 44 | 22,522 | 9,069.2344 | 9,840.16406 | 27 | white | 18 | 32 | 0.480957 | 0.408997 | 1 | 1 | 0 | no | 0.15 | 0.1 | dnr after sadm | 2 | 107 | 6.199219 | 100 | 20 | 38.19531 | null | 4.299805 | 0.399963 | 1 | 140 | null | 102 | 14 | 1,445 | null | 7 | <2 mo. follow-up | 7 |
1,553 | 79.65796 | 1 | male | 0 | 5 | 84 | Lung Cancer | Cancer | 1 | 11 | under $11k | 0 | 10,991 | 5,674.75 | 6,170.38672 | 10 | black | 12.798828 | 23 | 0.75293 | 0.495972 | 1 | 0 | 0 | metastatic | 0.8 | 0.4 | dnr after sadm | 1 | 38 | 1 | 145 | 40 | 39.19531 | 78.75 | null | 10 | 2.699707 | 130 | 7.5 | 117 | 81 | 1,315 | 6 | 5 | adl>=4 (>=5 if sur) | 5 |
1,554 | 18.502 | 0 | female | 0 | 44 | 386 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | under $11k | 37 | 327,791 | 124,510.062 | 121,448.562 | 37.25 | hispanic | 28.398438 | 43 | 0.785889 | 0.715942 | 3 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 44 | 115 | 15.099609 | 125 | 20 | 38.5 | null | 5.699219 | null | 0.699951 | 149 | null | 151 | 20 | 3,865 | null | null | SIP>=30 | 2.486328 |
1,555 | 62.52197 | 1 | male | 1 | 13 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 16 | $11-$25k | 41 | 279,274 | 61,933.125 | 60,556.7812 | 56.5 | hispanic | 28.097656 | 51 | 0.412964 | 0.293945 | 12 | 0 | 0 | yes | 0.15 | 0.05 | dnr after sadm | 11 | 48 | 15.298828 | 105 | 6 | 36.19531 | 303.3125 | 3.299805 | 1.099854 | 2.5 | 142 | 7.399414 | 169 | 43 | 2,025 | null | 7 | <2 mo. follow-up | 7 |
1,556 | 66.15198 | 0 | male | 0 | 22 | 384 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 80,163 | 36,860.3125 | 31,019.375 | 22 | black | 32.296875 | 52 | 0.638916 | 0.457947 | 2 | 1 | 0 | no | 0.95 | 0.85 | no dnr | 22 | 115 | 2.299805 | 125 | 28 | 38.79688 | 356 | null | 17.597656 | 1.099854 | 136 | 7.379883 | 243 | 34 | 5,026 | 5 | 4 | adl>=4 (>=5 if sur) | 4 |
1,557 | 86.37097 | 0 | male | 0 | 4 | 383 | CHF | COPD/CHF/Cirrhosis | 3 | null | under $11k | 9 | 9,019 | 5,309.8047 | 4,714.75781 | 20 | white | 20.199219 | 31 | 0.757935 | 0.616943 | 1 | 0 | 1 | no | 0.9 | 0.75 | dnr after sadm | 2 | 70 | 7.5 | 65 | 20 | 36 | 266.625 | null | null | 0.799927 | 143 | 7.5 | 322 | 16 | 1,350 | null | null | null | 5.987305 |
1,558 | 59.31 | 1 | female | 0 | 11 | 242 | MOSF w/Malig | ARF/MOSF | 1 | 14 | >$50k | 0 | 63,881 | 27,277.3281 | 23,431.3594 | 29.5 | white | 32.898438 | 55 | 0.487976 | 0.369995 | 1 | 0 | 0 | yes | 0.9 | 0.7 | no dnr | 11 | 62 | 2.299805 | 105 | 31 | 39.29688 | 162 | 2.199707 | 2.299805 | 1.599854 | 151 | 7.549805 | 148 | 78 | 2,126 | 5 | 5 | SIP>=30 | 5 |
1,559 | 68.34198 | 1 | male | 1 | 24 | 24 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 26 | null | null | null | 33.666657 | white | 25.796875 | 29 | 0.596924 | 0.406982 | 12 | 0 | 0 | no | 0.75 | 0.75 | null | null | 58 | 15.199219 | 90 | 12 | 36.29688 | null | null | 8 | 5.799805 | 145 | null | null | 130 | 2,145 | null | 1 | <2 mo. follow-up | 1 |
1,560 | 26.14099 | 1 | male | 1 | 8 | 8 | MOSF w/Malig | ARF/MOSF | 3 | 14 | under $11k | 44 | 87,952 | 30,212.125 | 30,602.7188 | 44.5 | hispanic | 30.796875 | 59 | 0.337952 | 0.221985 | 3 | 0 | 0 | yes | 0.85 | 0.85 | dnr after sadm | 7 | 75 | 23.5 | 76 | 20 | 37 | 242.84375 | null | null | 1.099854 | 132 | 7.439453 | 136 | 24 | 4,200 | null | 0 | <2 mo. follow-up | 0 |
1,561 | 51.26099 | 1 | male | 0 | 49 | 205 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 41 | 230,224 | 96,777.375 | 90,802.4375 | 30.5 | white | 39.09375 | 39 | 0.302979 | 0.190979 | 4 | 0 | 1 | no | 0.8 | 0.4 | dnr before sadm | 0 | 102 | 17.296875 | 95 | 20 | 36 | 116.3125 | 3.199707 | 1.399902 | 1.5 | 136 | 7.419922 | 180 | 39 | 2,295 | null | null | null | 5.682617 |
1,562 | 67.09399 | 0 | female | 0 | 68 | 381 | COPD | COPD/CHF/Cirrhosis | 2 | 14 | under $11k | 0 | 433,012 | 163,304.625 | 166,759.125 | 36.25 | white | 20.796875 | 21 | 0.794922 | 0.670898 | 2 | 0 | 0 | yes | 1 | 1 | no dnr | 68 | 125 | 14.398438 | 55 | 8 | 38.89844 | 322.5 | null | null | 0.699951 | 134 | 7.469727 | 315 | 15 | 2,055 | null | 4 | null | 4 |
1,563 | 60.26599 | 0 | female | 0 | 5 | 380 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | $25-$50k | 0 | 13,646 | 7,869.8555 | 6,478.39844 | 19 | black | 15 | 8 | 0.914917 | 0.855957 | 1 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 5 | 65 | 15 | 125 | 40 | 38.89844 | 262.8125 | null | null | 0.799927 | 152 | 7.519531 | 244 | 30 | 2,795 | 0 | null | null | 0.494751 |
1,564 | 72.375 | 1 | female | 0 | 11 | 309 | COPD | COPD/CHF/Cirrhosis | 4 | 18 | >$50k | 26 | 53,913 | 20,428.3906 | 17,345.5938 | 20 | white | 36.796875 | 44 | 0.294983 | 0.118988 | 3 | 0 | 0 | no | 0.65 | 0.65 | no dnr | 11 | 46 | 30.796875 | 170 | 48 | 36.39844 | 255 | null | 0.899902 | 5.099609 | 140 | 7.359375 | 158 | 89 | 349 | null | null | null | 5.023438 |
1,565 | 47.60599 | 0 | female | 0 | 20 | 365 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | >$50k | 26 | 174,923 | 31,521.7031 | 31,668.875 | 19.333328 | white | 23.796875 | 34 | 0.68396 | 0.590942 | 13 | 0 | 0 | yes | 0.85 | 0.7 | no dnr | 20 | 83 | 6.299805 | 100 | 22 | 38 | null | null | null | 1.5 | 138 | null | null | 22 | 2,850 | null | 0 | null | 0 |
1,566 | 65.25397 | 1 | female | 0 | 17 | 142 | Coma | Coma | 1 | 18 | $25-$50k | 44 | 149,859 | 38,738.5938 | 41,645.5938 | 32.666657 | white | 21 | 26 | 0.506958 | 0.435974 | 5 | 0 | 0 | no | 0.55 | 0.5 | no dnr | 17 | 58 | 14.798828 | 75 | 38 | 37.89844 | 526.5 | null | null | 0.799927 | 141 | 7.389648 | 144 | 11 | 1,150 | null | 0 | adl>=4 (>=5 if sur) | 0 |
1,567 | 54.103 | 1 | male | 0 | 52 | 227 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 467,237 | 167,344.375 | 164,658.375 | 51.75 | white | 41.796875 | 80 | 0.478943 | 0.359985 | 1 | 0 | 0 | no | 0.05 | 0.05 | no dnr | 52 | 63 | 6.599609 | 78 | 20 | 37.89844 | null | null | null | 1.299805 | 138 | null | 152 | 21 | 1,500 | null | 0 | null | 0 |
1,568 | 65.71698 | 1 | female | 1 | 41 | 41 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 18 | >$50k | 37 | 460,259 | 173,739.375 | 184,564.75 | 49 | asian | 21.097656 | 31 | 0.746948 | 0.666992 | 1 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 41 | 65 | 14.199219 | 140 | 15 | 39.5 | 182.21875 | 1.799805 | 3 | 0.5 | 141 | 7.389648 | 236 | 8 | 3,835 | null | 1 | <2 mo. follow-up | 1 |
1,569 | 83.06598 | 0 | female | 0 | 17 | 362 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 18 | null | 9 | 118,843 | 29,307.4219 | 28,632.1875 | 22.666656 | black | 18.699219 | 26 | 0.603882 | 0.497986 | 16 | 0 | 0 | metastatic | 0.5 | 0.15 | no dnr | 17 | 72 | 3 | 70 | 31 | 38.09375 | 135 | null | 2.799805 | 0.899902 | 148 | 7.539062 | 398 | 41 | 4,700 | null | 1 | null | 1 |
1,570 | 85.45099 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 20 | null | 94 | 65,216 | null | null | 33.5 | white | 38.09375 | 60 | 0.007 | 0.001 | 1 | 0 | 0 | yes | 0.3 | 0.3 | no dnr | 7 | 78 | 10.898438 | 125 | 22 | 38.19531 | 122.4375 | null | 0.299988 | 4.899414 | 133 | 7.319336 | 373 | 117 | 1,475 | null | null | <2 mo. follow-up | 4.566406 |
1,571 | 74.37396 | 0 | male | 0 | 10 | 360 | CHF | COPD/CHF/Cirrhosis | 4 | 6 | $11-$25k | 0 | 23,855 | null | null | 11.5 | white | 14.199219 | 19 | 0.891968 | 0.81897 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 10 | 75 | 9.298828 | 64 | 12 | 36.59375 | null | 3.399902 | 1.199951 | 1.599854 | 134 | null | 97 | 24 | 2,950 | 0 | 0 | no(M2 and SIP pres) | 0 |
1,572 | 67.81696 | 1 | male | 1 | 13 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | null | under $11k | 55 | 56,904 | 22,632.4375 | 20,936.9688 | 30.5 | white | 32.398438 | 70 | 0.257996 | 0.152985 | 2 | 1 | 0 | yes | 0.1 | 0 | dnr after sadm | 2 | 113 | 0.049995 | 130 | 11 | 39.09375 | null | 1.899902 | null | 0.5 | 135 | null | 114 | 15 | 4,684 | null | 7 | <2 mo. follow-up | 7 |
1,573 | 76.099 | 0 | female | 0 | 9 | 356 | COPD | COPD/CHF/Cirrhosis | 4 | 19 | $11-$25k | 9 | 53,633 | 15,800.9922 | 15,465.1797 | 16.5 | white | 30.296875 | 54 | 0.319946 | 0.136993 | 6 | 0 | 0 | metastatic | 0.6 | 0.5 | no dnr | 9 | 75 | 15.798828 | 115 | 10 | 36.39844 | 222.5 | null | 4.199219 | 0.799927 | 133 | 7.419922 | null | 20 | 2,420 | 0 | 0 | no(M2 and SIP pres) | 0 |
1,574 | 63.978 | 1 | female | 0 | 11 | 185 | Colon Cancer | Cancer | 1 | 13 | $11-$25k | 0 | 21,967 | 11,803.8203 | 11,124.2969 | 13.5 | white | 19.699219 | 19 | 0.779907 | 0.539917 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 11 | 73 | 0.599976 | 70 | 14 | 39.09375 | 153.03125 | null | 3.199707 | 1.599854 | 141 | 7.399414 | null | 30 | 3,295 | 1 | null | null | 1.166748 |
1,575 | 80.50397 | 1 | male | 1 | 4 | 4 | Coma | Coma | 2 | null | null | 55 | 23,637 | 9,525.2812 | 10,073.8672 | 23 | white | 21.597656 | 20 | 0.346985 | 0.274963 | 1 | 1 | 1 | no | 0.9 | 0.9 | dnr before sadm | -1 | 48 | 10.898438 | 55 | 10 | 36.19531 | 41 | null | null | 0.899902 | 134 | 7.549805 | 109 | 20 | 2,460 | null | null | <2 mo. follow-up | 4.599609 |
1,576 | 60.69299 | 0 | male | 0 | 3 | 355 | CHF | COPD/CHF/Cirrhosis | 2 | 15 | null | 0 | 8,561 | 3,575.4902 | 3,659.09961 | 28 | white | 16 | 19 | 0.906982 | 0.842896 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 3 | 72 | 21.296875 | 115 | 24 | 38.19531 | 272 | null | null | 0.699951 | 135 | 7.30957 | 173 | 7 | 2,180 | 0 | 0 | no(M2 and SIP pres) | 0 |
1,577 | 72.01898 | 1 | male | 0 | 24 | 58 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 26 | 136,226 | 57,056.75 | 54,969.0625 | 36.333313 | white | 36.796875 | 41 | 0.337952 | 0.221985 | 2 | 0 | 0 | no | 0.85 | 0.8 | no dnr | 24 | 78 | 5.299805 | 80 | 20 | 36 | null | null | null | 1.099854 | 139 | null | 110 | 16 | 3,800 | null | 0 | <2 mo. follow-up | 0 |
1,578 | 54.73798 | 0 | male | 0 | 17 | 352 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 156,205 | 84,656 | 68,870.875 | 34.333313 | white | 32 | 31 | 0.72998 | 0.576904 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 17 | 62 | 13.199219 | 115 | 35 | 37.89844 | 103.32812 | null | null | 0.399963 | 126 | 7.319336 | null | 2 | 1,000 | 0 | 1 | no(M2 and SIP pres) | 1 |
1,579 | 45.85898 | 0 | female | 0 | 34 | 352 | Coma | Coma | 0 | 12 | null | 44 | 502,025 | 102,793.438 | 94,954.875 | 31.5 | white | 31.5 | 34 | 0.335999 | 0.263977 | 31 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 34 | 106 | 17.597656 | 105 | 26 | 36.89844 | 301 | null | null | 0.399963 | 143 | 7.619141 | 209 | 28 | 1,590 | null | 0 | adl>=4 (>=5 if sur) | 0 |
1,580 | 63.53998 | 1 | male | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | $25-$50k | 44 | 647,638 | 142,198.625 | 129,240.75 | 51 | hispanic | 45 | 83 | 0.044998 | 0.014 | 27 | 0 | 0 | no | 0.05 | 0.02 | dnr after sadm | 21 | 120 | 10.298828 | 120 | 25 | 37.79688 | 210 | null | null | 1.199951 | 142 | 7.5 | null | 15 | 3,445 | null | 0 | <2 mo. follow-up | 0 |
1,581 | 84.70599 | 1 | female | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 19 | >$50k | 44 | 26,000 | 11,751.9062 | 11,874.8828 | 17 | white | 25.296875 | 51 | 0.434998 | 0.314941 | 1 | 0 | 1 | yes | 0.7 | 0.4 | dnr after sadm | 2 | 67 | 15.898438 | 175 | 14 | 39.19531 | 135.6875 | 4.199219 | 9.599609 | 2.799805 | 156 | 7.459961 | 196 | 83 | 6,910 | null | null | <2 mo. follow-up | 5.836914 |
1,582 | 63.017 | 1 | male | 0 | 9 | 31 | Lung Cancer | Cancer | 1 | 27 | >$50k | 0 | 26,494 | 13,606.3359 | 14,991.0469 | 13 | white | 17.398438 | 8 | 0.704956 | 0.419983 | 1 | 0 | 0 | metastatic | 1 | 0.6 | no dnr | 9 | 132 | 21.296875 | 105 | 24 | 38 | 288.5625 | 2.299805 | 1 | 0.799927 | 130 | 7.439453 | null | 24 | 6,603 | 0 | null | <2 mo. follow-up | 0.494751 |
1,583 | 30.741 | 0 | female | 0 | 56 | 346 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 89 | 364,515 | 188,889.25 | 159,707.125 | 34.75 | black | 34.09375 | 62 | 0.407959 | 0.28894 | 1 | 0 | 0 | no | 0.6 | 0.4 | no dnr | 56 | 68 | 12.699219 | 95 | 29 | 36.79688 | 250 | null | null | 1 | 137 | 7.5 | 147 | 22 | 2,028 | null | 0 | no(M2 and SIP pres) | 0 |
1,584 | 29.10899 | 1 | female | 0 | 8 | 29 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 26 | 44,220 | 16,745.4844 | 17,332.9219 | 24 | white | 25.796875 | 32 | 0.822998 | 0.763916 | 2 | 0 | 0 | no | 0.75 | 0.7 | no dnr | 8 | 60 | 19.296875 | 135 | 20 | 37 | 70 | 2.599609 | null | 2.5 | 131 | 7.239258 | 92 | 80 | 1,109 | null | null | <2 mo. follow-up | 3.044922 |
1,585 | 59.31 | 0 | male | 0 | 5 | 346 | Colon Cancer | Cancer | 1 | 15 | >$50k | 0 | null | null | null | 11 | white | 13.699219 | 11 | 0.86499 | 0.697998 | 1 | 0 | 0 | metastatic | 1 | 0.95 | null | null | 69 | 8.5 | 105 | 24 | 36 | null | 4.199219 | 0.799927 | 1.199951 | 142 | null | 117 | 18 | 1,810 | null | null | no(M2 and SIP pres) | 1.873047 |
1,586 | 49.76898 | 1 | female | 1 | 86 | 86 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $25-$50k | 37 | null | null | null | 47 | white | 25.699219 | 46 | 0.650879 | 0.550903 | 15 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 46 | 45 | 7.899414 | 125 | 28 | 37.79688 | 322.8125 | 2.599609 | null | 8.199219 | 143 | 7.40918 | 293 | 58 | 0 | null | null | adl>=4 (>=5 if sur) | 3.320313 |
1,587 | 47.978 | 0 | male | 0 | 6 | 345 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 23,716 | 9,634.25 | 9,722.29688 | 34 | white | 27.199219 | 47 | 0.832886 | 0.726929 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 6 | 122 | 9.5 | 120 | 30 | 38 | 75.5 | null | null | 0.899902 | 132 | 7.519531 | null | 19 | 2,560 | null | null | null | 2.381836 |
1,588 | 65.17999 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 14 | >$50k | 100 | 218,454 | 27,713.5 | 30,207.5469 | 55 | white | 44.59375 | 81 | 0.002 | 0 | 11 | 1 | 0 | no | 0.1 | 0.1 | dnr after sadm | 4 | 73 | 10 | 136 | 20 | 38.59375 | null | null | 0.099991 | 0.699951 | 135 | null | null | 13 | 4,500 | null | 1 | <2 mo. follow-up | 1 |
1,589 | 69.92694 | 1 | male | 0 | 20 | 308 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 13 | under $11k | 44 | 94,568 | 38,181.5312 | 41,316.8125 | 32 | white | 29.398438 | 57 | 0.417969 | 0.29895 | 1 | 0 | 0 | yes | 0.6 | 0.4 | no dnr | 20 | 83 | 17.898438 | 95 | 24 | 38.29688 | 150 | null | 0.699951 | 1.299805 | 149 | 7.5 | 431 | 37 | 3,850 | null | null | SIP>=30 | 3.505859 |
1,590 | 66.57599 | 1 | male | 1 | 5 | 5 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 4,971 | 3,593.7559 | null | 12 | white | 48.898438 | 66 | 0.063995 | 0.001 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 64 | 13.898438 | 64 | 24 | 36.79688 | 81.65625 | 2.799805 | 20.398438 | 2.399902 | 131 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,591 | 42.23999 | 1 | male | 1 | 4 | 4 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 16,101 | 9,690.9844 | null | 17 | white | 49.695313 | 68 | 0.125977 | 0.026997 | 12 | 0 | 0 | no | 0.9 | 0.8 | dnr after sadm | 4 | 67 | 15 | 92 | 20 | 34.69531 | null | 2.399902 | 30.597656 | 4.599609 | 117 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
1,592 | 61.13599 | 1 | male | 0 | 8 | 14 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 7,688 | 2,069.8438 | null | 7.5 | white | 22.398438 | 26 | 0.740967 | 0.475952 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 1 | 90 | 10.398438 | 90 | 25 | 37 | null | 2.599609 | 0.799927 | 1.799805 | 139 | null | null | null | null | 2 | 1 | <2 mo. follow-up | 1 |
1,593 | 71.18994 | 1 | male | 0 | 4 | 211 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 3,214 | 2,426.2617 | null | 11 | black | 19.5 | 26 | 0.80188 | 0.680908 | 1 | 0 | 0 | yes | 0.99 | 0.98 | no dnr | 4 | 107 | 15.298828 | 78 | 28 | 36.29688 | 400 | null | null | 1.599854 | 142 | 7.449219 | null | null | null | null | null | SIP>=30 | 2.578125 |
1,594 | 59.59799 | 1 | male | 0 | 7 | 37 | Lung Cancer | Cancer | 2 | 15 | null | 0 | 7,063 | 5,217 | null | 11 | white | 28.398438 | 17 | 0.438965 | 0.129974 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 7 | 82 | 18 | 92 | 32 | 38 | 308 | 3.099609 | 0.899902 | 0.799927 | 124 | 7.479492 | null | null | null | null | null | <2 mo. follow-up | 3.402832 |
1,595 | 65.81 | 0 | male | 0 | 8 | 2,029 | CHF | COPD/CHF/Cirrhosis | 1 | 15 | null | 0 | 7,104 | 5,181.7969 | null | 9.5 | black | 12.099609 | 26 | 0.922974 | 0.869995 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 8 | 113 | 5.399414 | 100 | 20 | 37.59375 | 380.9375 | 4.5 | null | 1.799805 | 143 | 7.479492 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,596 | 67.88495 | 0 | female | 0 | 8 | 2,028 | CHF | COPD/CHF/Cirrhosis | 3 | 7 | under $11k | 0 | 7,143 | 5,452.7578 | null | 8 | white | 25.296875 | 48 | 0.782959 | 0.652954 | 1 | 0 | 0 | no | 0.95 | 0.75 | dnr after sadm | 1 | 60 | 11.199219 | 64 | 25 | 36 | 252 | 4 | 0.599976 | 5.399414 | 129 | 7.5 | null | null | null | 1 | null | null | 1.1669 |
1,597 | 42.70499 | 1 | male | 0 | 5 | 17 | Lung Cancer | Cancer | 1 | 14 | $11-$25k | 0 | 6,662 | 4,805.4062 | null | 20 | white | 24.597656 | 11 | 0.5979 | 0.278992 | 1 | 0 | 0 | metastatic | null | 0.3 | no dnr | 5 | 73 | 7.5 | 72 | 24 | 36.19531 | null | 2.699707 | 0.199982 | 0.699951 | 136 | null | null | null | null | 5 | 6 | <2 mo. follow-up | 6 |
1,598 | 79.35095 | 1 | male | 0 | 10 | 31 | CHF | COPD/CHF/Cirrhosis | 4 | 7 | under $11k | 0 | 10,774 | 8,725.1875 | null | 8 | white | 21.199219 | 28 | 0.750977 | 0.606934 | 1 | 1 | 0 | yes | 0.8 | 0.5 | no dnr | 10 | 101 | 10.699219 | 74 | 16 | 36.09375 | 155.09375 | 4.299805 | null | 1.899902 | 131 | 7.359375 | null | null | null | 2 | 1 | <2 mo. follow-up | 1 |
1,599 | 34.14398 | 1 | female | 1 | 16 | 16 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 100 | 44,464 | 19,419.25 | null | 43.333313 | white | 42.898438 | 71 | 0.100998 | 0.042 | 1 | 0 | 0 | no | 0.83 | 0.83 | dnr after sadm | 13 | 45 | 17.097656 | 158 | 40 | 37.5 | 121.65625 | 2.799805 | 3.5 | 1.399902 | 145 | 7.539062 | null | null | null | null | null | <2 mo. follow-up | 4.136719 |
1,600 | 85.12799 | 1 | female | 0 | 8 | 101 | COPD | COPD/CHF/Cirrhosis | 1 | 10 | under $11k | 0 | 11,331 | 6,966.8047 | null | 12.5 | hispanic | 20.398438 | 41 | 0.708984 | 0.54895 | 3 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 8 | 76 | 7.099609 | 102 | 24 | 36.59375 | 209.5 | 3.099609 | 0.399963 | 0.899902 | 134 | 7.5 | null | null | null | 2 | null | null | 1.839 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.